Joint investment BMM, CTMM and TI Pharma
The Netherlands’ three Top Institutes for life-science research (the BioMedical Materials program, the Center for Translational Molecular Medicine and Top Institute Pharma) today announced a joint investment of M€ 28 on innovative research targeted at bringing personalized medicine closer to reality. The projects funded by the group will focus on developing new ways of delivering drugs to specific disease sites within the human body, thereby reducing the required doses, minimizing unwanted side effects and increasing the drugs’ effectiveness. Together with the development of tailored drug therapies, the imaging guided and targeted drug delivery techniques that these newly funded projects aim to develop, are widely regarded as one of the keys to highly personalized medicine.
